Ionizable Calixarene-Crown Ethers with High Selectivity for Radium over Light Alkaline Earth Metal Ions

Overview

Journal Inorg Chem

Specialty Chemistry

Date 2011 Apr 16

PMID 21494420

Citations 10

Authors

Xiaoyuan Chen

Min Ji

Darrell R Fisher

Chien M Wai

Affiliations

Soon will be listed here.

Citing Articles

Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.

Trencsenyi G, Csikos C, Kepes Z Int J Mol Sci. 2024; 25(1).

PMID: 38203834 PMC: 10779852. DOI: 10.3390/ijms25010664.

The Curies' element: state of the art and perspectives on the use of radium in nuclear medicine.

Franchi S, Asti M, Di Marco V, Tosato M EJNMMI Radiopharm Chem. 2023; 8(1):38.

PMID: 37947909 PMC: 10638329. DOI: 10.1186/s41181-023-00220-4.

A comparative evaluation of calix[4]arene-1,3-crown-6 as a ligand for selected divalent cations of radiopharmaceutical interest.

Bauer D, Blumberg M, Kockerling M, Mamat C RSC Adv. 2022; 9(55):32357-32366.

PMID: 35530789 PMC: 9072984. DOI: 10.1039/c9ra07293d.

Synthesis of Ionizable Calix[4]arenes for Chelation of Selected Divalent Cations.

Blumberg M, Al-Ameed K, Eiselt E, Luber S, Mamat C Molecules. 2022; 27(5).

PMID: 35268577 PMC: 8911665. DOI: 10.3390/molecules27051478.

Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".

Eychenne R, Cherel M, Haddad F, Guerard F, Gestin J Pharmaceutics. 2021; 13(6).

PMID: 34207408 PMC: 8234975. DOI: 10.3390/pharmaceutics13060906.

References

Schlom J, Siler K, Milenic D, Eggensperger D, Colcher D, Miller L . Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate. Cancer Res. 1991; 51(11):2889-96. View

Sharkey R, Kaltovich F, Shih L, FAND I, Govelitz G, Goldenberg D . Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 1988; 48(11):3270-5. View

Moi M, Meares C, Denardo S . The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex. J Am Chem Soc. 2011; 110(18):6266-7. DOI: 10.1021/ja00226a063. View

Roberts J, Adams Y, Tomalia D, Lavallee D . Using starburst dendrimers as linker molecules to radiolabel antibodies. Bioconjug Chem. 1990; 1(5):305-8. DOI: 10.1021/bc00005a001. View

CRAM D . Cavitands: organic hosts with enforced cavities. Science. 1983; 219(4589):1177-83. DOI: 10.1126/science.219.4589.1177. View

Geerlings M . Radionuclides for radioimmunotherapy: criteria for selection. Int J Biol Markers. 1993; 8(3):180-6. DOI: 10.1177/172460089300800308. View

Deshpande S, Denardo S, Meares C, McCall M, Adams G, Denardo G . Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Int J Rad Appl Instrum B. 1989; 16(6):587-97. DOI: 10.1016/0883-2897(89)90075-5. View

Ruser G, Ritter W, Maecke H . Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111. Bioconjug Chem. 1990; 1(5):345-9. DOI: 10.1021/bc00005a008. View

Moi M, Meares C, McCall M, Cole W, Denardo S . Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. Anal Biochem. 1985; 148(1):249-53. DOI: 10.1016/0003-2697(85)90653-0. View

10.

Koppel G . Recent advances with monoclonal antibody drug targeting for the treatment of human cancer. Bioconjug Chem. 1990; 1(1):13-23. DOI: 10.1021/bc00001a002. View

11.

Pedersen C . The discovery of crown ethers. Science. 1988; 241(4865):536-40. DOI: 10.1126/science.241.4865.536. View

12.

Dietz M, Chiarizia R, Horwitz E, Bartsch R, Talanov V . Effect of crown ethers on the ion-exchange behavior of alkaline Earth metals. Toward improved ion-exchange methods for the separation and preconcentration of radium. Anal Chem. 2011; 69(15):3028-37. DOI: 10.1021/ac9700437. View

13.

ORDER S, Klein J, Leichner P, Frincke J, Lollo C, Carlo D . 90Yttrium antiferritin--a new therapeutic radiolabeled antibody. Int J Radiat Oncol Biol Phys. 1986; 12(2):277-81. DOI: 10.1016/0360-3016(86)90110-0. View